General MedicationsORALGeneric
RIBAVIRIN
RIBAVIRIN
Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview RIBAVIRIN is listed in Drugs@FDA under application 202546 (ANDA).
Marketing status: Discontinued Active ingredient RIBAVIRIN Form and strength TABLET;ORAL - 200MG Sponsor BEXIMCO PHARMS USA Submission history Latest submission status date: 2014-08-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview RIBAVIRIN is listed in Drugs@FDA under application 202546 (ANDA). Marketing status: Discontinued Active ingredient RIBAVIRIN Form and strength TABLET;ORAL - 200MG Sponsor BEXIMCO PHARMS USA Submission history Latest submission status date: 2014-08-12 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.